D. Boral Capital analyst Jason Kolbert initiated coverage of Beyond Air (XAIR) with a Buy rating and $11 price target The firm says the company’s LungFit platform represents a “disruptive leap” in nitric oxide delivery. It enables on-demand generation from ambient air without the need for high-pressure gas cylinders or chemical cassettes, the analyst tells investors in a research note. Boral believes new indications represent out-year revenue drivers for Beyond Air.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XAIR:
- Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested
- Beyond Air trading halted, news pending
- Beyond Air Implements Reverse Stock Split for Nasdaq Compliance
- Beyond Air Approves Reverse Stock Split Proposal
- Beyond Air Faces Nasdaq Delisting Risk: Investor Confidence and Market Visibility at Stake